134 related articles for article (PubMed ID: 14568264)
1. Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection.
Dalekos GN; Obermayer-Straub P; Bartels M; Maeda T; Kayser A; Braun S; Loges S; Schmidt E; Gershwin ME; Manns MP
J Hepatol; 2003 Nov; 39(5):800-6. PubMed ID: 14568264
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
[TBL] [Abstract][Full Text] [Related]
3. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1.
Clemente MG; Meloni A; Obermayer-Straub P; Frau F; Manns MP; De Virgiliis S
Gastroenterology; 1998 Feb; 114(2):324-8. PubMed ID: 9453493
[TBL] [Abstract][Full Text] [Related]
4. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
[TBL] [Abstract][Full Text] [Related]
7. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity.
Bogdanos DP; McFarlane IG
J Hepatol; 2003 Nov; 39(5):860-3. PubMed ID: 14568272
[No Abstract] [Full Text] [Related]
9. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
10. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
Obermayer-Straub P; Strassburg CP; Manns MP
Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
[TBL] [Abstract][Full Text] [Related]
11. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Obermayer-Straub P; Perheentupa J; Braun S; Kayser A; Barut A; Loges S; Harms A; Dalekos G; Strassburg CP; Manns MP
Gastroenterology; 2001 Sep; 121(3):668-77. PubMed ID: 11522751
[TBL] [Abstract][Full Text] [Related]
12. High levels of autoantibodies against drug-metabolizing enzymes in SLA/LP-positive AIH-1 sera.
Shinoda M; Tanaka Y; Kuno T; Matsufuji T; Matsufuji S; Murakami Y; Mizutani T
Autoimmunity; 2004; 37(6-7):473-80. PubMed ID: 15621574
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
[TBL] [Abstract][Full Text] [Related]
14. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
[TBL] [Abstract][Full Text] [Related]
15. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Mol Biol Rep; 1996; 23(3-4):235-42. PubMed ID: 9112234
[TBL] [Abstract][Full Text] [Related]
17. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
[TBL] [Abstract][Full Text] [Related]
18. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
20. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]